Bethel Advance (bitter orange, mulberry leaf, cassia seed extract, jobstear seed, spirulina, star...
FDA Drug Recall #D-372-2014 — Class I — August 5, 2013
Recall Summary
| Recall Number | D-372-2014 |
| Classification | Class I — Serious risk |
| Date Initiated | August 5, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Bethel Nutritional Consulting, Inc |
| Location | New York, NY |
| Product Type | Drugs |
| Quantity | 13,266 bottles |
Product Description
Bethel Advance (bitter orange, mulberry leaf, cassia seed extract, jobstear seed, spirulina, starch, kola nut) capsules, 400 mg, 30-count bottles, Distributed by: Bethel, Inc., Tel: (212) 568-5330, UPC 1 60126 41750 9.
Reason for Recall
Marketed Without An Approved NDA/ANDA: FDA analyses detected the presence of phenolphthalein, N-di-Desmethylsibutramine, and trace amounts of sibutramine and N-Desmethylsibutramine. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs.
Distribution Pattern
Nationwide, Puerto Rico, and internet sales
Lot / Code Information
Lot 10092011, Exp 2014
Other Recalls from Bethel Nutritional Consulting, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1207-2015 | Class I | SLIM-K, 30 Capsules, barcode 160126417509, Dist... | Dec 19, 2014 |
| D-0424-2015 | Class II | B-Lipo, 30 Capsules, Manufactured by KM DALI, K... | Dec 19, 2014 |
| D-371-2014 | Class I | Quick Thin (citrus aurantium extract, sweet pot... | Aug 5, 2013 |
| D-921-2013 | Class I | Bethel 30 capsules, packaged in 30 count bottle... | Jun 11, 2013 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.